Stand out for this role — generate a tailored resume and cover letter in about a minute.
Orion Pharma is seeking a Senior Specialist, Bioanalytical Outsourcing to lead outsourced quantitative bioanalysis programs for non-clinical and clinical studies. Based in Espoo, Turku, or Cambridge UK with hybrid work, you will coordinate CROs, ensure GLP/GCP compliance, and deliver high-quality data to inform development decisions.
You will manage method development, validation, sample analysis and regulatory submissions, collaborating with internal stakeholders and partners to drive timely,
Espoo, Finland and 1 more (Hybrid)
Your role
We are seeking an experienced Senior Specialist, Bioanalytical Outsourcing with strong scientific and regulatory know-how on bioanalysis in both biologics and small molecules to join our Quantitative Bioanalytical & Biomarker organization in R&D. In this role, you will serve as the primary scientific and operational lead for outsourced quantitative bioanalytical activities at Contract Research Organisations (CROs) ensuring high-quality assay execution, regulatory compliance, and timely delivery of data critical for decision-making throughout the drug development process. You will also act as Sourcing Manager taking care of purchasing the quantitative bioanalytics from CROs. The main tasks for this position are to source and manage method development, validation and sample analysis at CROs supporting non-clinical (non-GLP and GLP) and clinical studies in close collaboration with other Orion stakeholders.
This is a full-time scientific position within the Bioanalytical outsourcing group within the Quantitative Bioanalytical and Biomarker organization in R&D based in Espoo or Turku, Finland or Cambridge UK. In this role, you will report to Head of Quantitative Bioanalytics & Biomarkers.
Responsibilities
What you can expect from us
At Orion Pharma, your work creates true impact and well-being for our customers, patients and society at large. Our culture of friendliness, respect, mutual appreciation and diversity creates a safe working environment where you can stride for excellence. We offer a wealth of career paths and development opportunities that support the development of innovative solutions and improving the quality of life.
Personal Attributes
Your new team
Orion’s pharmaceutical innovations are created within its R&D organization. We employ over 400 top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Nottingham and Cambridge in the UK, and in Cambridge, MA, USA. Orion R&D and the Innovative Medicines business division are dedicated to making a transformation to become a global player in the pain and oncology therapy areas.
For further information about the position, please contact: Mika Pykäläinen, Head of Quantitative Bioanalytics & Biomarkers: mika.pykalainen (at) orionpharma.com
Approved medical examination which also includes drug testing is required prior to the employment. We will also carry out a security clearance prior to the employment for the selected person.
#LI-ORION
Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years.
We’re home to more than 4,000 Orionees around the world, and we’re proud to be known as a responsible employer and a great place to work. At Orion Pharma, people are truly valued and trusted, encouraged to grow, and supported by a culture where every voice is heard. We appreciate each other, strive for excellence, and build the future.
Together we develop, manufacture, and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines as well as consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Pharma are used to treat cancer, neurological diseases, respiratory diseases, and more.
We offer careers with a clear purpose: empowering people to live their lives to the fullest.